Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligometastases”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Testing effectiveness (Phase 2)Looking for participantsNCT05277844
What this trial is testing

Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC

Who this might be right for
Oligometastatic DiseaseNon-small Cell Lung CancerDriver Mutation
Tata Memorial Hospital 106
Not applicableActive Not RecruitingNCT02933242
What this trial is testing

Stereotactic Ablative Body Radiotherapy (SABR) for Oligometastases

Who this might be right for
Metastatic Tumors
British Columbia Cancer Agency 399
Not applicableUnknownNCT03427541
What this trial is testing

Explore Prognoses of NSCLC Patients Complicated With Oligometastases

Who this might be right for
Non Small Cell Lung Cancer
Tang-Du Hospital 1,000
Testing effectiveness (Phase 2)UnknownNCT03557411
What this trial is testing

A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Hypofraction Radiotherapy in Patients With NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer
Shandong Cancer Hospital and Institute 42
Early research (Phase 1)Looking for participantsNCT04925583
What this trial is testing

Magnetic Resonance Guided Adaptive Stereotactic Body Radiotherapy for Lung Tumors in Ultracentral Location

Who this might be right for
Lung Cancer
University Hospital Heidelberg 38
Testing effectiveness (Phase 2)Study completedNCT01761929
What this trial is testing

5 Fraction Stereotactic Body Radiation Therapy for Oligometastases Regimen, for Extra-Cranial Oligometastases

Who this might be right for
Solid Tumors With Oligometastatic Spread
University Health Network, Toronto 138
Not applicableLooking for participantsNCT04805255
What this trial is testing

A Neurocognitive Study in Patients With Brain Oligometastases Receiving Hypofractionated SRT

Who this might be right for
Brain Metastases, Adult
Chang Gung Memorial Hospital 135
Not applicableWithdrawnNCT03532204
What this trial is testing

Oligometastases of the LIVer Treated With Chemotherapy With ou Without Extracranial Stereotactic Body Radiation Therapy in Patients With Colorectal Cancer

Who this might be right for
Liver MetastasesColorectal Cancer
UNICANCER
Not applicableStudy completedNCT03878485
What this trial is testing

Pilot Study of Same-session MR-only Simulation and Treatment With Stereotactic MRI-guided Adaptive Radiotherapy (SMART) for Oligometastases of the Spine

Who this might be right for
Oligometastases of the Spine
Washington University School of Medicine 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06143722
What this trial is testing

Synchronous or Sequential Radiotherapy for Advanced Esophageal Squamous Cell Carcinoma With Oligometastases.

Who this might be right for
Advanced Esophageal Squamous Carcinoma With Oligometastases
West China Hospital 63
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05484583
What this trial is testing

Durvalumab Combined With Consolidation Radiotherapy After First-line Treatment in Extensive Stage Small Cell Lung Cancer With Oligometastases

Who this might be right for
Lung CancerExtensive-stage Small-cell Lung CancerRadiotherapy
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 58
Not applicableUnknownNCT04407897
What this trial is testing

SOFT- Stereotactic Ablative Radiotherapy of Infra-diaphragmatic Soft Tissue Metastases

Who this might be right for
Solid TumorOligometastasesSoft Tissue Disease
Herlev Hospital 121
Testing effectiveness (Phase 2)UnknownNCT01898962
What this trial is testing

Definitive Therapy for Oligometastatic Solid Malignancies

Who this might be right for
Stage IV or Recurrent Carcinoma or Sarcoma
Rocky Mountain Cancer Centers 110
Testing effectiveness (Phase 2)Looking for participantsNCT06680050
What this trial is testing

Phase II Study of Radiotherapy Followed by Durvalumab and Ceralasertib in Stage III NSCLC Patients With Thoracic Relapses +/- Oligometastases After PACIFIC Regimen

Who this might be right for
Non Small Cell Lung Cancer NSCLC
Mario Negri Institute for Pharmacological Research 21
Not applicableStudy completedNCT02414334
What this trial is testing

SABR-SCAN Trial for Pulmonary Oligometastases

Who this might be right for
Oligometastases
University Medical Center Groningen 40
Not applicableLooking for participantsNCT07415356
What this trial is testing

Adaptive Fractionation in Online Adaptive Stereotactic Radiotherapy for Abdominopelvic Lymph Node Oligometastases

Who this might be right for
Lymph Node Oligometastases
Joost J. M. E. Nuyttens 25
Testing effectiveness (Phase 2)UnknownNCT05626569
What this trial is testing

Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaOligometastatic Disease
Sun Yat-sen University 40
Not applicableNot Yet RecruitingNCT06882499
What this trial is testing

Stereotactic Ablative Body Radiotherapy (SABR) with Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II

Who this might be right for
Breast Cancer, MetastaticMetastatic Breast Cancer
Peter MacCallum Cancer Centre, Australia 74
Testing effectiveness (Phase 2)Looking for participantsNCT06850103
What this trial is testing

SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases

Who this might be right for
Colorectal CarcinomaOligometastasespMMR+2 more
First Affiliated Hospital of Zhejiang University 102
Testing effectiveness (Phase 2)Active Not RecruitingNCT04443062
What this trial is testing

Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer
Radboud University Medical Center 58
Load More Results